arrow
J

Joyce van Sluis

university medical center groningen
H指数:15
被引数:1,162

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study

作者更正:大B细胞淋巴瘤患者治疗前及CD19定向CAR T细胞疗法期间全身CD8+ T细胞PET成像:一项2期研究

2026-02-100
OAAI
Delayed [89Zr]Zr-N-Succinyldesferal-Trastuzumab Imaging Enabled by Long-Axial-Field-of-View PET/CT

Mohr, P.; Li, Z.; van Sluis, J.; Lub-de Hooge, M.N.; van den Brom, R.R.H.; Lammertsma, A.A.; Tsoumpas, C.; Brouwers, A.H. 利用长轴向视野PET/CT实现延迟[(89)Zr]Zr-N-琥珀酰去铁胺-曲妥珠单抗显像。J. Nucl. Med. 2026, 67, 160–161. [Google Scholar] [CrossRef]

2026-01-011
PRE
Yttrium-90 Selective Internal Radiation Therapy for Neuroendocrine Liver Metastases: An Institutional Case Series, Updated Systematic Review, and Meta-Analysis

90Y选择性内部放射治疗用于神经内分泌性肝脏转移:一项机构病例系列研究、更新的系统评价和荟萃分析

2025-12-300
OAAI
Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study

大B细胞淋巴瘤患者CD8+ T细胞全身PET成像:在CD19靶向CAR T细胞治疗前后及治疗期间进行的一项2期研究

2025-11-250
OAAI
Phase I study to assess biodistribution of CB307, a trispecific Humabody targeting CD137, prostate-specific membrane antigen, and human serum albumin with 89Zr-CB307 PET

I期研究评估CB307的生物分布情况,CB307是一种靶向CD137、前列腺特异性膜抗原和人血清白蛋白的三特异性Humabody,并通过89Zr-CB307 PET进行检测。

2024-09-010
PRE